Mark Alan Rosen, MD, PhD

faculty photo
Associate Professor of Radiology at the Hospital of the University of Pennsylvania
Medical Staff, Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA
Medical Staff, Department of Radiology , Penn-Presbyterian Medical Center, Philadelphia, PA
Medical Staff, Department of Radiology, Pennsylvania Hospital, Philadelphia, PA
Chief, Division of Abdominal Imaging - Department of Radiology, Hospital of the of the University of Pennsylvania, Philadelphia, PA
Department: Radiology

Contact information
Department of Radiology
Hospital of the University of Pennsylvania
1 Silverstein
3400 Spruce Street
Philadelphia, PA 19104-4283
Office: 215-662-3107
Fax: 215-662-7263
B.A. (Chemistry)
Amherst College, 1986.
M.D. (Medicine)
Columbia University, 1994.
Ph.D. (Biochemistry)
Columbia University, 1994.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

Functional Tumor MR Imaging: DCE-MRI, DWI, MRSI
Morphologic Tumor Response Evaluation

Description of Clinical Expertise

Radiology, Abdominal Imaigng, MRI & CT

Selected Publications

Lee SH, Geng H, Arnold J, Caruana R, Fan Y, Rosen MA, Apte AP, Deasy JO, Bradley JD, Xiao Y. : Interpretable Machine Learning for Choosing Radiation Dose-volume Constraints on Cardio-pulmonary Substructures Associated with Overall Survival in NRG Oncology RTOG 0617 Int J Radiat Oncol Biol Phys. 23: 591-596, Jun 2023.

Narasimhamurthy M, Savant D, Shreve L, Rosen MA, Lee MK, Cooper K, Furth EE, Zhang PJ, Yang Z. : Myofibroblastoma in the Liver: A Case Report and Review of Literature Int J Surg Pathol. Mar 2023.

Smith K, Ulin K, Knopp M, Kry S, Xiao Y, Rosen M, Michalski J, Iandoli M, Laurie F, Quigley J, Reifler H, Santiago J, Briggs K, Kirby S, Schmitter K, Prior F, Saltz J, Sharma A, Bishop-Jodoin M, Moni J, Cicchetti MG, FitzGerald TJ. : Quality improvements in radiation oncology clinical trials Front Oncol. 13, Jan 2023.

Boss MA, Snyder BS, Kim E, Flamini D, Englander S, Sundaram KM, Gumpeni N, Palmer SL, Choi H, Froemming AT, Persigehl T, Davenport MS, Malyarenko D, Chenevert TL, Rosen MA. : Repeatability and Reproducibility Assessment of the Apparent Diffusion Coefficient in the Prostate: A Trial of the ECOG-ACRIN Research Group (ACRIN 6701) J Magn Reson Imaging 56(3), Sep 2022.

Romanello Joaquim M, Furth EE, Fan Y, Song HK, Pickup S, Cao J, Choi H, Gupta M, Cao Q, Shinohara R, McMenamin D, Clendenin C, Karasic TB, Duda J, Gee JC, O'Dwyer PJ, Rosen MA, Zhou R. : DWI Metrics Differentiating Benign Intraductal Papillary Mucinous Neoplasms from Invasive Pancreatic Cancer: A Study in GEM Models Cancers (Basel) 14(16), Aug 2022.

Mettikanont P, Kalluri A, Bittermann T, Phillips N, Loza BL, Rosen M, Siegelman E, Furth E, Abt P, Olthoff K, Shaked A, Hoteit M, Reddy KR. : The Course of LIRADS 3 and 4 Hepatic Abnormalities as Correlated With Explant Pathology: A Single Center Experience J Clin Exp Hepatol 4: 1048-1056, Jul 2022.

Wattenberg MM, Asch D, Yu S, O'Dwyer PJ, Domchek SM, Nathanson KL, Rosen MA, Beatty GL, Siegelman ES, Reiss KA: Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation. Br J Cancer Feb 2020.

Partridge SC, Newitt DC, Chenevert TL, Rosen MA, Hylton NM; ACRIN 6698 Trial Team and I-SPY 2: Diffusion-weighted MRI in Multicenter Trials of Breast Cance. Radiology 2(291): 546, May 2019.

Scheel JR, Kim E, Partridge SC, Lehman CD, Rosen MA, Bernreuter WK, Pisano ED, Marques HS, Morris EA, Weatherall PT, Polin SM, Newstead GM, Esserman LJ, Schnall MD, Hylton NM: MRI, Clinical Examination, and Mammography for Preoperative Assessment of Residual Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: ACRIN 6657 Trial. AJR Am J Roentgenol 210(6): 1376-1385, Jun 2018.

Baumann BC, Wei J, Plastaras JP, Lukens JN, Damjanov N, Hoteit M, Hsu C, Levine M, Mondschein J, Nadolski G, Olthoff K, Reiss KA, Rosen M, Siegelman E, Metz JM, Ben-Josef E: Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma: High Rates of Local Control With Low Toxicity. Am J Clin Oncol 41(11): 1118-1124, Mar 2018 Notes: doi: 10.1097/COC.0000000000000435.

back to top
Last updated: 09/22/2023
The Trustees of the University of Pennsylvania